Кислородно-озоновая терапия как адъювант при SARS-COV-2 инфекции: клиническое исследование

Oxygen-ozone Therapy as Adjuvant in the Current Emergency in SARS-COV-2 Infection: A Clinical Study

Promoter of the study: NUOVA F.I.O. (Italian Oxygen-Ozone Federation); S Marini 1, M Maggiorotti 2, N Dardes 3, M Bonetti 4, M Martinelli 5, L Re 6, F Carinci 7, C Tavera 8 Affiliations

• 1 Dati & Ricerca S.r.l., Rome, Italy.

• 2 New FIO National Secretary, Rome, Italy.

• 3 Paideia Clinic, Rome, Italy.

• 4 New FIO.

• 5 Villa S. Pietro Hospital, Rome, Italy.

• 6 Medinat, Camerano, Ancona, Italy.

• 7 Dental Faculty, University of Ferrara, Ferrara, Italy.

• 8 Potenziativa Medical Center, Como, Italy.

PMID: 32462858

DOI: 10.23812/20-250-E-56

Abstract

The aim of the multicentre study promoted by Nuova FIO is to evaluate the beneficial effects of the systemic Oxygen-Ozone (O2O3) therapy in patients suffering from SARS COV-2 disease in the early phases of the disease, before worsening, up to the need of tracheal intubation. The study is based on the rationale on that the systemic oxygen-ozone treatment could be effective, positively influencing the disease evolution and/or being able to mitigate the onset of the cytokine storm syndrome at least partially.

Keywords:

#COVID19 #SARS_COV_2 #clinicalstudy #oxygen_ozone #protocol

Copyright 2020 Biolife Sas. www.biolifesas.org